Cervical cancer trials in China

In China 159 Also abroad 532

159 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Where
Beijing, Changde, Changsha, Chengdu, Chongqing, Fuzhou, Ganzhou, Guangzhou, Hangzhou, Harbin, Kunming, Lanzhou, Linyi, Luzhou, Nanchang, Shandong, Shanghai, Shenyang, Shenzhen, Tianjin, Wuhan, Xi'an, Yibin, Yinchuan, Zhengzhou, Zhuzhou
Age
15 years and over
People
800 worldwide
Run by
AstraZeneca
See details and how to joinNCT06079671 · EU 2023-504374-38-00
Phase 2Taking people
Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer
Where
Beijing, Changsha, Chengdu, Chongqing, Dalian, Fuzhou, Guangzhou, Guilin, Ha’erbin, Hangzhou, Jinan, Jining, Kunming, Lanzhou, Luoyang, Nanchang, Nanjing, Shanghai, Shenyang, Shenzhen, Taiyuan, Tianjin, Wuhan, Xi’an, Yibin, Zhengzhou
Age
18 years to 70 years
People
100
Run by
Grit Biotechnology
See details and how to joinNCT06241781
No phaseEnrolling by invitation
Use of cfDNA in Monitoring and Guiding Treatment for Cervical Cancer
Where
Beijing
Age
18 years to 70 years
People
100
Run by
Peking Union Medical College Hospital
See details and how to joinNCT07919431
Phase 1/2Taking people
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Where
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fujian, Guangdong, Hangzhou, Henan, Hubei, Nanchang, Shanghai, Shanxi, Shengyang, Tianjin
Age
18 years and over
People
952 worldwide
Run by
Genmab
See details and how to joinNCT05579366
Phase 1Taking people
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Where
Beijing, Guangzhou, Shanghai
Age
18 years and over
People
460 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06465069 · EU 2024-512927-36-00
Phase 2Taking people
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Where
Beijing, Changsha, Hangzhou, Shanghai
Age
18 years and over
People
111 worldwide
Run by
Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00
Phase 3Taking people
Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer
Where
Beijing
Age
18 years to 75 years
People
440
Run by
Peking Union Medical College Hospital
See details and how to joinNCT06641635
No phaseNot yet taking people in China
Immunotherapy in Neuroendocrine Carcinoma of the Cervix
Where
Beijing
Age
18 years to 100 years
People
150
Run by
Peking Union Medical College Hospital
See details and how to joinNCT07911423
Phase 2Taking people
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Where
Beijing, Changsha, Chengdu, Dongguan, Henan, Hubei, Shanghai, Shenyang, Wuhan, Xi'an, Xinxiang, Xuzhou
Age
18 years and over
People
750 worldwide
Run by
DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00
No phaseTaking people
Hydrogel Spacer During Definitive Radiotherapy for Cervical Cancer
Where
Tianjin
Age
17 years to 75 years
People
30
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07904182
Phase 2Taking people
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Where
Chengdu, Guangzhou
Age
18 years and over
People
740 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00
No phaseTaking people
Feasibility of the "One-Finger Technique" for Identifying the Upper Left Ureter During Para-Aortic Lymphadenectomy
Where
Guangzhou
Age
18 years to 75 years
People
40
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07895212
Phase 1/2Taking people
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Where
Baoding, Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Ganzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Linyi, Luoyang, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Taizhou, Tianjin, Wuhan, Xi’an, Xinxiang, Zhengzhou
Age
18 years and over
People
862 worldwide
Run by
DualityBio Inc.
See details and how to joinNCT05914116
No phaseNot yet taking people in China
Multi-omics Study of Cervical Neuroendocrine Carcinoma
Where
Beijing
Age
18 years to 100 years
People
120
Run by
Peking Union Medical College Hospital
See details and how to joinNCT07879339
Phase 2Taking people
Iparomlimab/Tuvonralimab Combined With Nab-paclitaxel and Cisplatin as Neoadjuvant Therapy for Locally Advanced Cervical Cancer
Where
Xi'an
Age
18 years to 70 years
People
34
Run by
Xijing Hospital
See details and how to joinNCT07876154
Phase 2Taking people
A Study of YL202 in Patients With Advanced Solid Tumors
Where
Changsha
Age
18 years and over
People
100
Run by
MediLink Therapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT07202364
Phase 1/2Taking people
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Where
Beijing, Fuzhou, Guangzhou, Shandong, Shanghai
Age
18 years and over
People
233 worldwide
Run by
Ensem Therapeutics
See details and how to joinNCT06993844
No phaseTaking people
Stellate Ganglion Block and Dexmedetomidine for Postoperative Sleep in Women Undergoing Laparoscopic Gynecologic Surgery
Where
Huai'an
Age
18 years to 75 years
People
100
Run by
Catherin Zhang
See details and how to joinNCT07860203
No phaseEnrolling by invitation
CNCMT：a Multi-center, Prospective, Single-arm Study
Where
Wuhan
Age
18 years to 75 years
People
20
Run by
Hubei Cancer Hospital
See details and how to joinNCT06714084
Phase 3Taking people
A Study of GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer
Where
Shanghai
Age
18 years to 75 years
People
424
Run by
Guangzhou Gloria Biosciences Co., Ltd.
See details and how to joinNCT05798819
No phaseTaking people
MH-ART vs CF-IMRT in Postoperative Cervical/Endometrial Cancer
Where
Beijing
Age
18 years to 75 years
People
228
Run by
Xiaorong Hou
See details and how to joinNCT07584161
Phase 2Taking people
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Where
Anyang, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Dongguan, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jining, Kunming, Nanchang, Nanjing, Nanning, Shandong, Shanghai, Shenyang, Tianjin, Wuhan, Wuhou District, Zhengzhou
Age
18 years to 64 years
People
257 worldwide
Run by
AstraZeneca
See details and how to joinNCT06535607 · EU 2025-523947-36-00
Phase 2Not yet taking people in China
Perioperative Adebrelimab for Locally Advanced Cervical Cancer
Where
Hefei
Age
18 years to 75 years
People
35
Run by
Anhui Provincial Hospital
See details and how to joinNCT07811375
No phaseTaking people
Electroacupuncture on Postoperative Urinary Retention After Radical Surgery for Cervical Cancer
Where
Hangzhou
Age
18 years to 70 years
People
208
Run by
Lu Chao
See details and how to joinNCT07253194
Phase 3Not yet taking people in China
JSKN033 Versus Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer
Where
Guangzhou, Shanghai
Age
18 years and over
People
368
Run by
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
See details and how to joinNCT07797153